Post-earnings recap
Reported
Fri, Feb 7, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
AbbVie's earnings report showed a slight miss on EPS, but the stock reacted positively, rising 5.86%. Investors may be encouraged by management's focus on product strength and future launches, which could drive growth despite the EPS miss.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.21 | N/A | -1.33% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in their pipeline and future prospects despite missing EPS expectations. They emphasized the strength of their existing products.
Management highlighted ongoing strength in key product lines.
They noted the importance of upcoming product launches for future growth.